Profil
Elizabeth Alcamo is an Entrepreneur-in-Residence at Versant Venture Management LLC.
She previously worked as a Director at Adverum Biotechnologies, Inc. from 2014 to 2016, as a Senior Director at 4D Molecular Therapeutics, Inc. from 2016 to 2017, and as a Vice President at CODA Biotherapeutics, Inc. from 2018 to 2019.
Ms. Alcamo holds a doctorate degree from Massachusetts Institute of Technology, which she obtained in 2000, and an undergraduate degree from Williams College, which she obtained in 1990.
Aktiva positioner av Elizabeth Alcamo
| Företag | Position | Start |
|---|---|---|
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Privat kapitalinvesterare | 2020-10-01 |
Tidigare kända positioner av Elizabeth Alcamo
| Företag | Position | Slut |
|---|---|---|
CODA Biotherapeutics, Inc.
CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology Develops chemo genetic neuromodulation platform for the treatment of severe neurological disorders | Företagsledare/Principal | 2019-05-01 |
| 4D MOLECULAR THERAPEUTICS, INC. | Företagsledare/Principal | 2017-06-01 |
| ADVERUM BIOTECHNOLOGIES, INC. | Företagsledare/Principal | 2016-04-01 |
Elizabeth Alcamos utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Williams College
Williams College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops gene therapies | Health Technology |
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
CODA Biotherapeutics, Inc.
CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology Develops chemo genetic neuromodulation platform for the treatment of severe neurological disorders | Health Technology |
















